Provides that individuals may receive breast cancer screenings under an insurance plan when such individual has a second degree relative with a prior history of breast cancer.
Summary
Bill A01158 amends the New York insurance law to expand eligibility for breast cancer screenings covered by insurance plans. Specifically, it allows individuals to receive mammograms upon the recommendation of a physician if they have a prior history of breast cancer or if they have a first or second degree relative with a prior history of the disease. This change aims to enhance early detection and preventive care for those at risk due to familial ties.
The bill modifies existing provisions in sections 3216 and 3221 of the insurance law, ensuring that the coverage for mammograms includes those with a second degree relative diagnosed with breast cancer. This amendment is intended to align insurance coverage with current medical understanding of hereditary risks associated with breast cancer, thereby potentially improving health outcomes through earlier screenings.
The bill is set to take effect sixty days after it becomes law and will apply to all relevant insurance policies issued or renewed thereafter. This means that once enacted, insurance companies will need to adjust their policies to comply with the new coverage requirements for breast cancer screenings.
Overall, the sentiment surrounding the bill appears to be positive, as it addresses a significant health issue and aims to provide better access to preventive care for individuals at risk of breast cancer. However, there may be some concerns regarding the financial implications for insurance providers and how this could affect premiums or coverage options in the long term.
Impact
The passage of Bill A01158 will have a direct impact on the insurance landscape in New York, specifically regarding coverage for breast cancer screenings. By including second degree relatives in the criteria for coverage, the bill expands access to preventive healthcare services for individuals who may not have been eligible under previous regulations. This change is expected to lead to increased screenings, which could result in earlier detection of breast cancer, ultimately improving patient outcomes. Additionally, insurance companies will need to update their policies and procedures to comply with the new law, potentially affecting their operational costs and pricing structures.
Sentiment
The general sentiment around Bill A01158 is favorable, as it seeks to enhance access to critical health screenings for individuals at risk of breast cancer. Stakeholders, including healthcare advocates and patient support groups, have expressed support for the bill, highlighting its potential to save lives through early detection. However, there may be apprehensions from insurance companies regarding the financial implications of expanded coverage, which could lead to discussions about the sustainability of such mandates in the long run.
Contention
Notable points of contention may arise primarily from insurance providers who could be concerned about the increased costs associated with expanding coverage to include second degree relatives. There may be debates about the financial burden this places on the insurance market and whether it could lead to higher premiums for consumers. Additionally, some lawmakers may question the necessity of including second degree relatives in the coverage criteria, arguing that it could lead to over-screening or unnecessary healthcare expenditures.
Same As
Provides that individuals may receive breast cancer screenings under an insurance plan when such individual has a second degree relative with a prior history of breast cancer.